|
PIP4K2A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.167000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.535200E-01 |
| Normal-vs-Stage2 |
1.823190E-01 |
| Normal-vs-Stage3 |
7.498200E-01 |
| Normal-vs-Stage4 |
1.528150E-01 |
| Stage1-vs-Stage2 |
9.723600E-03 |
| Stage1-vs-Stage3 |
7.946800E-01 |
| Stage1-vs-Stage4 |
8.754200E-02 |
| Stage2-vs-Stage3 |
1.618140E-02 |
| Stage2-vs-Stage4 |
2.615300E-03 |
| Stage3-vs-Stage4 |
1.464630E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.411200E-01 |
| Normal-vs-AfricanAmerican |
8.951800E-01 |
| Normal-vs-Asian |
7.813000E-01 |
| Caucasian-vs-AfricanAmerican |
7.093000E-01 |
| Caucasian-vs-Asian |
1.743240E-01 |
| AfricanAmerican-vs-Asian |
6.478000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.072400E-01 |
| Normal-vs-Female |
8.245200E-01 |
| Male-vs-Female |
9.598800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.645000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.337800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.554200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.747600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.559600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.469600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.852600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.530400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.509440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.140200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.031640E-01 |
| Classical-VS-Follicular |
1.43930000140458E-08 |
| Classical-VS-Other |
4.800200E-02 |
| Classical-VS-Normal |
3.916200E-01 |
| Tall-VS-Follicular |
4.68650000029491E-07 |
| Tall-VS-Other |
8.004500E-03 |
| Tall-VS-Normal |
7.915700E-02 |
| Follicular-VS-Other |
6.514400E-01 |
| Follicular-VS-Normal |
3.290100E-02 |
| Other-VS-Normal |
2.371400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.024600E-01 |
| Normal-vs-N1 |
6.715000E-01 |
| N0-vs-N1 |
7.500200E-02 |
|
|
